Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Further mechanism-of-action studies conducted on T-614

March 26, 1998

New mechanism identified for Fujisawa antiinflammatory agent

March 26, 1998

FDA okays protocol amendments for phase III trial of CBP-1011

March 26, 1998

UPMC leads the way in gene therapy for musculoskeletal disorders

March 25, 1998

P-gp as a complicating factor in childhood rheumatic diseases

March 24, 1998

Anergen files IND for AnergiX

March 24, 1998

Cyclic sulfones synthesized at Pfizer inhibit MMPs and TNF production

March 23, 1998

Antiinflammatory agents with a good safety profile disclosed by Taisho

March 23, 1998

Abbott describes novel lead structure for selective COX-2 inhibitors

March 19, 1998

Potent inhibitors of IL-1beta and TNF-alpha production prepared at Nisshin Flour Milling

March 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...